32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer

Clinical trial NCT00346281 · UNKNOWN

Trial details

NCT number: NCT00346281
Sponsor: pSiMedica Limited
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2006-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.